Prostate Cancer Medicine Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 LHRH Antagonists
1.2.3 LHRH Analogs
1.2.4 Antiandrogens
1.2.5 Pipeline Drugs for Hormonal Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Medicine Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2018-2029)
2.2 Prostate Cancer Medicine Growth Trends by Region
2.2.1 Prostate Cancer Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Medicine Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Medicine Market Dynamics
2.3.1 Prostate Cancer Medicine Industry Trends
2.3.2 Prostate Cancer Medicine Market Drivers
2.3.3 Prostate Cancer Medicine Market Challenges
2.3.4 Prostate Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Revenue
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
3.4 Global Prostate Cancer Medicine Market Concentration Ratio
3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2022
3.5 Prostate Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Medicine Product Solution and Service
3.7 Date of Enter into Prostate Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Medicine Breakdown Data by Type
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Medicine Breakdown Data by Application
5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Cancer Medicine Market Size (2018-2029)
6.2 North America Prostate Cancer Medicine Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Medicine Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2018-2029)
7.2 Europe Prostate Cancer Medicine Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Medicine Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Medicine Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Medicine Market Size (2018-2029)
9.2 Latin America Prostate Cancer Medicine Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Medicine Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Detail
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2018-2023)
11.1.5 AstraZeneca plc Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Detail
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Prostate Cancer Medicine Introduction
11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2018-2023)
11.2.5 Active Biotech Recent Development
11.3 Bristol Myers-Squibb
11.3.1 Bristol Myers-Squibb Company Detail
11.3.2 Bristol Myers-Squibb Business Overview
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2018-2023)
11.3.5 Bristol Myers-Squibb Recent Development
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Teva Pharmaceuticals Industries Ltd. Company Detail
11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2018-2023)
11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Detail
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2018-2023)
11.6.5 Pfizer Inc. Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Detail
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Prostate Cancer Medicine Introduction
11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2018-2023)
11.7.5 Bayer AG Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2018-2023)
11.8.5 Abbott Laboratories Recent Development
11.9 Astellas Pharma Inc.
11.9.1 Astellas Pharma Inc. Company Detail
11.9.2 Astellas Pharma Inc. Business Overview
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2018-2023)
11.9.5 Astellas Pharma Inc. Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Detail
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2018-2023)
11.10.5 Roche Holding AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of LHRH Antagonists
Table 3. Key Players of LHRH Analogs
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Pipeline Drugs for Hormonal Therapy
Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prostate Cancer Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Prostate Cancer Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prostate Cancer Medicine Market Share by Region (2018-2023)
Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Prostate Cancer Medicine Market Share by Region (2024-2029)
Table 12. Prostate Cancer Medicine Market Trends
Table 13. Prostate Cancer Medicine Market Drivers
Table 14. Prostate Cancer Medicine Market Challenges
Table 15. Prostate Cancer Medicine Market Restraints
Table 16. Global Prostate Cancer Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prostate Cancer Medicine Market Share by Players (2018-2023)
Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2022)
Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Medicine Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2018-2023)
Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2024-2029)
Table 29. Global Prostate Cancer Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2018-2023)
Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2024-2029)
Table 33. North America Prostate Cancer Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Prostate Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Prostate Cancer Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Prostate Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 39. Latin America Prostate Cancer Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 40. Latin America Prostate Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 41. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 43. AstraZeneca plc Company Detail
Table 44. AstraZeneca plc Business Overview
Table 45. AstraZeneca plc Prostate Cancer Medicine Product
Table 46. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 47. AstraZeneca plc Recent Development
Table 48. Active Biotech Company Detail
Table 49. Active Biotech Business Overview
Table 50. Active Biotech Prostate Cancer Medicine Product
Table 51. Active Biotech Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 52. Active Biotech Recent Development
Table 53. Bristol Myers-Squibb Company Detail
Table 54. Bristol Myers-Squibb Business Overview
Table 55. Bristol Myers-Squibb Prostate Cancer Medicine Product
Table 56. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 57. Bristol Myers-Squibb Recent Development
Table 58. Teva Pharmaceuticals Industries Ltd. Company Detail
Table 59. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 60. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product
Table 61. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 62. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 63. Johnson & Johnson Company Detail
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Prostate Cancer Medicine Product
Table 66. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Pfizer Inc. Company Detail
Table 69. Pfizer Inc. Business Overview
Table 70. Pfizer Inc. Prostate Cancer Medicine Product
Table 71. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 72. Pfizer Inc. Recent Development
Table 73. Bayer AG Company Detail
Table 74. Bayer AG Business Overview
Table 75. Bayer AG Prostate Cancer Medicine Product
Table 76. Bayer AG Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 77. Bayer AG Recent Development
Table 78. Abbott Laboratories Company Detail
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Prostate Cancer Medicine Product
Table 81. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. Astellas Pharma Inc. Company Detail
Table 84. Astellas Pharma Inc. Business Overview
Table 85. Astellas Pharma Inc. Prostate Cancer Medicine Product
Table 86. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 87. Astellas Pharma Inc. Recent Development
Table 88. Roche Holding AG Company Detail
Table 89. Roche Holding AG Business Overview
Table 90. Roche Holding AG Prostate Cancer Medicine Product
Table 91. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2018-2023) & (US$ Million)
Table 92. Roche Holding AG Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Medicine Market Share by Type: 2022 VS 2029
Figure 2. LHRH Antagonists Features
Figure 3. LHRH Analogs Features
Figure 4. Antiandrogens Features
Figure 5. Pipeline Drugs for Hormonal Therapy Features
Figure 6. Global Prostate Cancer Medicine Market Share by Application in 2022 & 2029
Figure 7. Age Below 55 Case Studies
Figure 8. Age 55-75 Case Studies
Figure 9. Age Above 75 Case Studies
Figure 10. Prostate Cancer Medicine Report Years Considered
Figure 11. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Prostate Cancer Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Prostate Cancer Medicine Market Share by Region: 2022 VS 2029
Figure 14. Global Prostate Cancer Medicine Market Share by Players in 2022
Figure 15. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2022
Figure 17. North America Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Prostate Cancer Medicine Market Share by Country (2018-2029)
Figure 19. United States Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Prostate Cancer Medicine Market Share by Country (2018-2029)
Figure 23. Germany Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2018-2029)
Figure 31. China Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Prostate Cancer Medicine Market Share by Country (2018-2029)
Figure 39. Mexico Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2018-2029)
Figure 43. Turkey Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 46. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 47. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 48. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 50. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 51. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 52. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 53. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 54. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
